Manufacturers in the chemical and biological products, medical devices and bio-active product sectors – including pharmaceuticals, cosmetics, antiseptics and disinfectants – can now benefit from an expanded range of accredited microbiological analyses available at our Plouzané laboratory in France.
On November 21, 2025, the Plouzané facility was accredited by the French Committee for Accreditation (Cofrac) to NF EN ISO/IEC 17025:2017, confirming the laboratory's technical competence and the robustness of its quality management system. Valid until October 31, 2029, this accreditation (No. 1‑7397) reinforces our ability to support these sectors with internationally recognized, high‑quality testing services.
Accredited microbiological expertise
ISO/IEC 17025 accreditation is internationally recognized as the benchmark for laboratories demonstrating the ability to produce accurate, traceable and reliable results. For manufacturers, this accreditation delivers tangible benefits, including:
- Reduced risk of regulatory non-compliance
- More efficient regulatory audits and inspections
- Mutual recognition of results, facilitating access to international markets
- Enhanced product safety and quality assurance
- Increased credibility with regulators, customers and other stakeholders
In response to increasingly stringent safety, performance and regulatory requirements for cosmetics, the Plouzané laboratory now provides accredited microbiological analyses, including:
- Antimicrobial protection tests (Challenge Test – NF EN ISO 11930) – validating the effectiveness of preservative systems and supporting regulatory submissions
- Microbiological cleanliness checks (ISO 17516) – ensuring formulas, ingredients and finished products meet strict microbiological criteria
The scope of accreditation also extends to key microbiological analyses for pharmaceutical and bio-active products, including:
- Preservative efficacy testing (European Pharmacopoeia 5.1.3)
- Microbiological cleanliness controls (PE 2.6.12)
Through accreditation, results are formally recognized, quality assurance is reinforced and technical support is provided for even the most complex formulations.
These services complement good manufacturing practice (GMP) analyses performed by our laboratory in Villeneuve‑la‑Garenne, creating a coherent, end‑to‑end quality chain for pharmaceutical and bio-active product testing.
360° solution
As part of the SGS global network, our Plouzané laboratory is now able to offer customers:
- End-to-end support across every stage of development
- Testing aligned with the strictest international standards to accelerate regulatory acceptance
- Tailored technical and regulatory guidance to address complex microbiological challenges
- A partner committed to innovation and scientific rigor
This milestone represents a significant step forward in strengthening our accredited capabilities for the chemical and biological products, medical devices and bio-active product sectors. By combining recognized expertise, rigorous quality systems and seamless integration within our global network, we further reinforce our position as a trusted leader in quality, safety and performance across industries.
For further information, please contact:
Jennifer Buckley
Senior Global Marketing Manager
Health & Nutrition
About SGS
SGS is the world’s leading Testing, Inspection and Certification company. We operate a network of over 2,500 laboratories and business facilities across 115 countries, supported by a team of 99,500 dedicated professionals. With over 145 years of service excellence, we combine the precision and accuracy that define Swiss companies to help organizations achieve the highest standards of quality, compliance and sustainability.
Our brand promise – when you need to be sure – underscores our commitment to trust, integrity and reliability, enabling businesses to thrive with confidence. We proudly deliver our expert services through the SGS name and trusted specialized brands, including Brightsight, Bluesign, Maine Pointe and Nutrasource.
SGS is publicly traded on the SIX Swiss Exchange under the ticker symbol SGSN (ISIN CH1256740924, Reuters SGSN.S, Bloomberg SGSN:SW).
